
Tamlago 0.4mg Tablet
Marketer
Inizia Healthcare Pvt Ltd
Salt Composition
Tamsulosin (0.4mg)
Overview Tamlago 0.4mg Tablet
Alfablok 0.4mg tablets are alpha-blockers indicated for managing benign prostatic hyperplasia (BPH). They alleviate urinary symptoms such as hesitancy, but don't shrink the prostate gland. Always follow your doctor's instructions regarding dosage and duration. This medication can be taken with or without food, but consistently at the same time each day. Swallow the tablet whole; do not crush or chew. Discontinue use only under medical supervision, as abrupt cessation may exacerbate symptoms. Complete the prescribed course for optimal results. Common side effects include dizziness, back pain, chest discomfort, ejaculatory dysfunction, and retrograde ejaculation. Report persistent or bothersome side effects to your physician immediately. Lifestyle modifications can aid symptom control. Void when the urge arises, but avoid straining. Limit evening and pre-sleep consumption of caffeine and alcohol. Before starting treatment, disclose all other medications and health conditions to your doctor. Inform your ophthalmologist about Alfablok use before any eye surgery (e.g., cataract or glaucoma procedures). Individuals with liver impairment require close monitoring and regular follow-up appointments as directed by their doctor.
Primary Ingredients of Tamlago 0.4mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Tamlago 0.4mg Tablet
Managing benign prostatic hyperplasia
Major Benefits of Tamlago 0.4mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the 0.4mg Tamlago tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or not, though consistent timing is recommended.
Common Side effects of Tamlago 0.4mg Tablet:
- Chest pain
- Inflammation of the nose
- Dizziness
- Ejaculation disorder
- Headache
- Abdominal pain
- Back pain
- Nausea
- Infection
How to use Tamlago 0.4mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the 0.4mg Tamlago tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.
How Tamlago 0.4mg Tablet works:
Tamlago 0.4mg tablets contain an alpha-adrenergic blocking agent. Its mechanism of action involves relaxing the muscles at the bladder neck and prostate, facilitating smoother urine flow. Consequently, bladder emptying is improved, lessening the frequency and urgency of urination associated with benign prostatic hyperplasia (BPH).
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Tamlago 0.4mg tablets and alcohol may result in significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on Tamlago 0.4mg Tablet use in pregnancy is absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Employing Tamlago 0.4mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant. This medication is contraindicated in lactating women.
DrivingSAFE
Driving ability is typically unaffected by Tamlago 0.4mg tablets.
KidneySAFE IF PRESCRIBED
Tamlago 0.4mg tablets are considered safe for individuals with kidney impairment; dosage modification is not typically necessary. Nevertheless, data regarding its use in patients with terminal kidney disease remains scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Tamlago 0.4mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Tamlago 0.4mg Tablet :
Should you forget a Tamlago 0.4mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tamlago 0.4mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Sulfonamide-based compound |
| Developing Habits | No. |
| Treatment Category | Urology |
